Members Capital Advisors Inc’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,445
Closed -$1.19M 30
2023
Q3
$1.19M Hold
4,445
1.48% 29
2023
Q2
$987K Sell
4,445
-1,727
-28% -$401K 1.01% 40
2023
Q1
$1.49M Hold
6,172
1.08% 45
2022
Q4
$1.62M Hold
6,172
1.17% 41
2022
Q3
$1.39M Hold
6,172
1.1% 43
2022
Q2
$1.5M Hold
6,172
1.09% 42
2022
Q1
$1.49M Hold
6,172
0.96% 58
2021
Q4
$1.39M Hold
6,172
0.71% 60
2021
Q3
$1.31M Hold
6,172
0.71% 58
2021
Q2
$1.5M Buy
+6,172
New +$1.52M 0.93% 47
2020
Q1
Sell
-8,241
Closed -$1.99M 3
2019
Q4
$1.99M Buy
+8,241
New +$1.82M 1.51% 3

Other funds holding AMGN

Members Capital Advisors Inc's AMGN Position: Q4 2023 in Review

Members Capital Advisors Inc sold out of Amgen (AMGN) in Q4 2023, closing a stake of 4,445 shares — an estimated $1.19M sold.

Members Capital Advisors Inc first reported a position in AMGN in Q4 2019 and held it in 11 quarters. The position peaked at $1.99M in Q4 2019. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Members Capital Advisors Inc reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Members Capital Advisors Inc sold 4,445 Amgen shares in Q4 2023, an estimated $1.19M.
  • Members Capital Advisors Inc first reported a position in Amgen in Q4 2019 and held it in 11 quarters.
  • Members Capital Advisors Inc's Amgen position peaked at $1.99M in Q4 2019.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Members Capital Advisors Inc's 13F filing for Q4 2023, filed 2 Feb 2024.